Literature DB >> 7067586

High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component.

D L Delacroix, M Reynaert, S Pauwels, A P Geubel, J P Vaerman.   

Abstract

Patients with liver disease frequently display unexplained elevations of serum secretory IgA (sIgA). The sIgA levels in various liver diseases were compared to various biochemical or clinical parameters. Patients with primary biliary cirrhosis, biliary tract obstruction, or acute hepatitis displayed highest sIgA levels. In chronic parenchymal liver disease sIgA levels correlated strongly with serum alkaline phosphatase (r = 0.79), leucine aminopeptidase (r = 0.83), and direct bilirubin levels (r = 0.63), but not with prothrombin time, aminopyrine breath test, or presence of portacaval shunting. In acute hepatitis sIgA correlated best with serum glutamic oxaloacetic transaminase (r = 0.69) but not with bilirubin; in four patients with fulminant hepatitis, sIgA fell rapidly together with all liver enzymes and prothrombin time; it rose quickly again in one patient when parenchymal regeneration occurred. These results suggest a hepatobiliary origin of the serum sIgA in liver disease. In acute hepatitis the persistence of hepatocytes seems necessary for maintaining high serum sIgA levels, suggesting a possible hepatocyte origin of the secretory component.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067586     DOI: 10.1007/bf01296753

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone.

Authors:  O D KOWLESSAR; L J HAEFFNER; E M RILEY; M H SLEISENGER
Journal:  Am J Med       Date:  1961-08       Impact factor: 4.965

2.  Studies on translocation of immunoglobulins across intestinal epithelium. II. Immunoelectron-microscopic localization of immunoglobulins and secretory component in human intestinal mucosa.

Authors:  W R Brown; Y Isobe; P K Nakane
Journal:  Gastroenterology       Date:  1976-12       Impact factor: 22.682

3.  In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes.

Authors:  U Hopf; P Brandtzaeg; T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  Studies on translocation of immunoglobulins across intestinal epithelium. IV. Evidence for binding of IgA and IgM to secretory component in intestinal epithelium.

Authors:  W R Brown; K Isobe; P K Nakane; B Pacini
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

5.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

Review 6.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  Human secretory component--VI. Immunoglobulin-binding properities.

Authors:  P Brandtzaeg
Journal:  Immunochemistry       Date:  1977-03

8.  A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum.

Authors:  D L Delacroix; J P Vaerman
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Arylamidases of rat liver and chemically induced hepatomas. 1. Subcellular distribution of L-leucine. 2. Naphthylamidase-active antigens.

Authors:  K Berzins; P Lando; M Raftell; F Blomberg
Journal:  Biochim Biophys Acta       Date:  1977-04-27

10.  Identification of secretory component as an IgA receptor on rat hepatocytes.

Authors:  D J Socken; K N Jeejeebhoy; H Bazin; B J Underdown
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more
  12 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

3.  Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction.

Authors:  G Ohshio; F Furukawa; T Manabe; T Tobe; Y Hamashima
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

4.  Secretory component (SC): preferential binding to heavy (greater than 11S) IgA polymers and IgM in serum, in contrast to predominance of 11S and free SC forms in secretions.

Authors:  D L Delacroix; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

5.  Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans.

Authors:  M R Versland; G Y Wu; F S Gorelick; J M Larkin
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

6.  Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients.

Authors:  C Vincent; G Cozon; M Zittoun; M Mellquist; M D Kazatchkine; C Czerkinsky; J P Revillard
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

7.  Plasma levels of secretory IgA in patients with gastric cancer.

Authors:  G Ohshio; H Kudo; H Yoshioka; A Nonaka; T Manabe; T Tobe; Y Hamashima
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva.

Authors:  D L Delacroix; H J Hodgson; A McPherson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Sources of proteins in human bile.

Authors:  B M Mullock; L J Shaw; B Fitzharris; J Peppard; M J Hamilton; M T Simpson; T M Hunt; R H Hinton
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

10.  Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A.

Authors:  D L Delacroix; K B Elkom; A P Geubel; H F Hodgson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.